Tevogen Bio Holdings Inc. Common Stock

TVGNNASDAQUSD
4.89 USD
0.43 (9.55%)🟢LIVE (AS OF 02:56 PM EDT)
🟢Market: OPEN
Open?$4.44
High?$5.05
Low?$4.36
Prev. Close?$4.46
Volume?21.7K
Avg. Volume?353.2K
VWAP?$4.63
Rel. Volume?0.06x
Bid / Ask
Bid?$4.30 × 100
Ask?$4.50 × 200
Spread?$0.20
Midpoint?$4.40
Valuation & Ratios
Market Cap?18.1M
Shares Out?4.2M
Float?44.9M
Float %?22.6%
P/E Ratio?N/A
P/B Ratio?-2.19
EPS?-$6.66
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.22Weak
Cash Ratio?0.08Low
Debt/Equity?-0.73Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
-2.19CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-0.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
327.4%STRONG
ROA?
-615.2%WEAK
Cash Flow & Enterprise
FCF?$-12393016
Enterprise Value?$23.6M
Related Companies
Loading...
News
Profile
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Employees
17
Market Cap
18.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-02-15
Address
15 INDEPENDENCE BOULEVARD, SUITE #210
WARREN, NJ 07059
Phone: 646-807-8832